Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TMDX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | James R. Tobin Director | TMDX TransMedics Group, Inc. | Sale | 4,000 | $94.98 | $379.9K Sale | Form 4 ↗ |
| Nov 9, 2026 | James R. Tobin Director | TMDX TransMedics Group, Inc. | Sale | 59 | $93.96 | $5,544 Sale | Form 4 ↗ |
| Sep 11, 2026 | David Weill Director | TMDX TransMedics Group, Inc. | Buy | 1,336 | $81.63 | $109.1K Buy | Form 4 ↗ |
| Jun 15, 2026 | Thomas J. Gunderson Director | TMDX TransMedics Group, Inc. | Sale | 9,624 | $75.06 | $722.4K Sale | Form 4 ↗ |
| Mar 4, 2026 | Stephanie Lovell Director | TMDX TransMedics Group, Inc. | Sale | 1,193 | $149.62 | $178.5K Sale | Form 4 ↗ |
| Mar 4, 2026 | David Weill Director | TMDX TransMedics Group, Inc. | Sale | 3,571 | $146.82 | $524.3K Sale | Form 4 ↗ |
| Mar 4, 2026 | Gerardo Hernandez Chief Financial Officer | TMDX TransMedics Group, Inc. | Sale | 5,912 | $147.21 | $870.3K Sale | Form 4 ↗ |
| Mar 4, 2026 | Gerardo Hernandez Chief Financial Officer | TMDX TransMedics Group, Inc. | Sale | 1,324 | $147.21 | $194.9K Sale | Form 4 ↗ |
| Mar 2, 2026 | Gerardo Hernandez Chief Financial Officer | TMDX TransMedics Group, Inc. | Sale | 375 | $139.12 | $52.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | Anil P. Ranganath See remarks | TMDX TransMedics Group, Inc. | Sale | 864 | $139.12 | $120.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | Nicholas Corcoran See remarks | TMDX TransMedics Group, Inc. | Sale | 2,966 | $139.12 | $412.6K Sale | Form 4 ↗ |
| Dec 4, 2025 | Gerardo Hernandez Chief Financial Officer | TMDX TransMedics Group, Inc. | Sale | 920 | $139.62 | $128.5K Sale | Form 4 ↗ |
| Dec 3, 2025 | David Weill Director | TMDX TransMedics Group, Inc. | Sale | 5,000 | $138.64 | $693.2K Sale | Form 4 ↗ |
| Nov 25, 2025 | Anil P. Ranganath See remarks | TMDX TransMedics Group, Inc. | Sale | 3,000 | $145.22 | $435.7K Sale | Form 4 ↗ |
| Nov 17, 2025 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Buy | 8,775 | $114.00 | $1.0M Buy | Form 4 ↗ |
| Oct 29, 2025 | Edward M. Basile Director | TMDX TransMedics Group, Inc. | Sale | 4,142 | $130.45 | $540.3K Sale | Form 4 ↗ |
| Aug 7, 2025 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Buy | 1,858 | $116.85 | $217.1K Buy | Form 4 ↗ |
| Aug 7, 2025 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Buy | 6,617 | $116.08 | $768.1K Buy | Form 4 ↗ |
| Aug 6, 2025 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Buy | 8,400 | $118.68 | $996.9K Buy | Form 4 ↗ |
| Aug 4, 2025 | Edward M. Basile Director | TMDX TransMedics Group, Inc. | Sale | 4,143 | $125.51 | $520.0K Sale | Form 4 ↗ |
| Jun 9, 2025 | Anil P. Ranganath See remarks | TMDX TransMedics Group, Inc. | Sale | 686 | $139.80 | $95.9K Sale | Form 4 ↗ |
| May 27, 2025 | Edward M. Basile Director | TMDX TransMedics Group, Inc. | Sale | 5,000 | $126.45 | $632.3K Sale | Form 4 ↗ |
| May 23, 2025 | David Weill Director | TMDX TransMedics Group, Inc. | Sale | 732 | $123.88 | $90.7K Sale | Form 4 ↗ |
| May 9, 2025 | Edward M. Basile Director | TMDX TransMedics Group, Inc. | Sale | 6,000 | $115.63 | $693.8K Sale | Form 4 ↗ |
| Mar 3, 2025 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 2,407 | $76.43 | $184.0K Sale | Form 4 ↗ |
| Jan 7, 2025 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 1,083 | $80.05 | $86.7K Sale | Form 4 ↗ |
| Dec 2, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 1,084 | $86.40 | $93.7K Sale | Form 4 ↗ |
| Nov 11, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 1,458 | $90.04 | $131.3K Sale | Form 4 ↗ |
| Nov 5, 2024 | Edward M. Basile Director | TMDX TransMedics Group, Inc. | Sale | 1,454 | $84.30 | $122.6K Sale | Form 4 ↗ |
| Nov 5, 2024 | Edward M. Basile Director | TMDX TransMedics Group, Inc. | Sale | 5,296 | $83.35 | $441.4K Sale | Form 4 ↗ |
| Nov 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 1,083 | $82.64 | $89.5K Sale | Form 4 ↗ |
| Oct 15, 2024 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Sale | 300 | $135.04 | $40.5K Sale | Form 4 ↗ |
| Oct 15, 2024 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Sale | 1,200 | $134.23 | $161.1K Sale | Form 4 ↗ |
| Oct 15, 2024 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Sale | 3,518 | $132.82 | $467.3K Sale | Form 4 ↗ |
| Oct 15, 2024 | Waleed H. Hassanein President & CEO, Director | TMDX TransMedics Group, Inc. | Sale | 3,607 | $131.91 | $475.8K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 134 | $154.86 | $20.8K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 20 | $153.75 | $3,075 Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 80 | $152.28 | $12.2K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 80 | $151.20 | $12.1K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 318 | $150.38 | $47.8K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 523 | $149.59 | $78.2K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 80 | $147.98 | $11.8K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 900 | $146.90 | $132.2K Sale | Form 4 ↗ |
| Oct 1, 2024 | Tamer I. Khayal Chief Commercial Officer | TMDX TransMedics Group, Inc. | Sale | 823 | $146.15 | $120.3K Sale | Form 4 ↗ |
44 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances